The IV™flow was designed for use with any gravitational device currently available on the market, as well as a host of additional products.
It is compatible with:
- Rigid, semi-rigid and collapsible containers (bags and bottles)
- Oncology sets and oncotherapy
- Blood and total parenteral nutrition (TPN) transfusion sets and products*
- Volumetric infusion pumps*
This major breakthrough is due to the fact that it is a value-adding device with no comparable product on the market. Advantages of the IV™flow outstrip ordinary gravity sets.
Due to its technical features and cost-efficiency, the IV™flow is a giant leap forward and an upgrade of existing gravitational infusion technology.
The IV™flow can also be used in conjunction with electronic infusion pumps, which are also sensitive to the hydrostatic pressure in the feedline and vulnerable to infusion containers running empty. The IV™flow will remain in place once a patient is moved from a high care ward where electronic infusion pumps have been used, to wards where these pumps are not available. This will enable other wards to benefit.
Dr. Jaco Makkink, medical doctor and consultant at MX Health, says that “studying the newly developed IV™flow, any critical clinician with experience in the usage of infusion sets immediately becomes aware of the numerous advantages or benefits of the new system’s technology over the currently used infusion set technology.
“As a clinician, one always has the patient’s best interests at heart, especially when administering medicines of any sort or when using infusion methods and technology. The infusion sets for administering fluid into the human body have been around for a very long time (old technology) and the accuracy and effectiveness of the art is to a very large extent taken for granted”. In this regard, the quote from Professor Eliyahu Goldratt’s book The theory of Constraints is relevant to the medical world:
“As long as
you think you know all, you stop re-thinking the
medical industry needs to seriously take note
of the improvement in and upgrade of this newly
developed infusion set. These improvements concern
both the consistency and accuracy of the clinical
infusion process itself (the most important aspect),
but also the management and control of the infusion
process which is far less dependent on the clinical
staff in attendance. It appears that medications
which is only administered via digitally controlled
drop counters, e.g. Theophylline which is given
to a patient with acute asthma, may very well
be effectively infused by incorporating this inexpensive
but very accurate IV™flow infusion device.
There must be a large
number of medical institutions and wards lacking
such electronic infusion pumps since they are
used in intensive care units. This means that
the IV™flow will be perfectly suited
to the markets where high quality health care
is needed, but at a reduced cost”.
"The care-effectiveness of the IV™flow was proven to be statistically significant and financially relevant.The inclusion of the IV™flow with standard gravitational IV-sets would enhance the quality of patient care and should reduce wastage associated with AE occurrences."
(Ref. SATRGAIT Trial, (Data on file Varori))
“The constant infusion rate, as a direct
result of the